+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

  • ID: 4668807
  • Report
  • November 2018
  • Region: Global
  • 15 Pages
  • Frost & Sullivan

The Life Science, Health & Wellness TOE encompasees recent advances in quantum dots,  diagnostics, treatment and drug discovery, and platforms that have the potential to transform the future of healthcare. The 12 disruptive innovations profiled in this publication include VIVODOTS™, Tetrapod quantum dots, Qdot® nanocrystals, QC/AI-driven platform, HSC therapy, In silico drug discovery, pharmacogenetics report, PSVT nasal therapy, AAV CDMO, LDL-C drug, neuroimaging, and HIV immunotherapy.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown

1. Innovations in Life Sciences, Health & Wellness
Exploring the Potential of Novel Platforms in Life Sciences
The VIVODOTS™ Project – Quantum Dots in Precision Oncology
Tetrapod QDs Films for On Site Diagnostics
Qdot® Bioconjugates in Multicolor Immunofluorescence Imaging
Quantum Computing and Artificial Intelligence in Drug Discovery
Allogenic Stem Cell Therapy for Inherited Metabolic Disorder
Comprehensive Drug Discovery Platform
Genetic Testing that Provides Pharmacogenetic Reports
Clinical Study of a Nasal Spray that Decreases High Heart Rates
Expert Adeno-associated virus (AAV) Vector Manufacturing
Positive Promising Results of Bempedoic Acid Treatment Program
A Novel Neuroimaging Agent in Trial for Measuring Brain Synapses
Novel HIV Immunotherapy Clears Phase 1 Clinical Study

2. Industry Relations
Regional Practice Leaders and Innovation Experts

Note: Product cover images may vary from those shown